Advisor Group’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Advisor Group’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Hold	0	–	–	–	5275
2019 Q2	–	Hold	0	–	–	–	5231
2019 Q1	–	Hold	0	–	–	–	5216
2016 Q4	–	Sell	-1	Closed	-$10K	–	4506
2016 Q3	$10K	Buy	+1	New	+$6.96K	﹤0.01%	3545

Other funds holding CANF

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Advisor Group's CANF Position: Q3 2019 in Review

Advisor Group held its Can-Fite BioPharma American Depositary Shares (CANF) position steady in Q3 2019 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5275.

Advisor Group first reported a position in CANF in Q3 2016 and has held it in 1 quarter since. The position peaked at $10K in Q3 2016. 5 funds tracked by Wall St. Rank hold CANF as of Q3 2019.

Advisor Group held 0 shares of Can-Fite BioPharma American Depositary Shares worth $0 as of Q3 2019.
Advisor Group left its Can-Fite BioPharma American Depositary Shares share count unchanged in Q3 2019.
Can-Fite BioPharma American Depositary Shares made up ﹤0.01% of Advisor Group's portfolio in Q3 2019, its #5275 holding.
Advisor Group first reported a position in Can-Fite BioPharma American Depositary Shares in Q3 2016 and has held it in 1 quarter since.
Advisor Group's Can-Fite BioPharma American Depositary Shares position peaked at $10K in Q3 2016.
5 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q3 2019.

Based on Advisor Group's 13F filing for Q3 2019, filed 13 Nov 2019.